rs117515728 - MPHOSPH10P1 - RBL2

Magnitude 2.2 · 2 studies on file

Reported associations

  • Genetic drivers of heterogeneity in type 2 diabetes pathophysiology - Unknown journal (n.d.) · Unknown authors · PubMed 38374256

    ABSTRACT: Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes and molecular mechanisms that are often specific to cell type. Here, to characterize the genetic contribution to these processes across ancestry groups, we aggregate genome-wide association study data from 2,535,601 individuals (39.7% not of European ancestry), including 428,452 cases of T2D. We identify 1,289 independent association signals at genome-wide significance (P < 5 × 10−8) that map to 611 loci, of which 145 loci are, to our knowledge, previously unreported. We define eight non-overlapping clusters of T2D signals that are characterized by distinct profiles of cardiometabolic trait associations. These clusters are differentially enriched for cell-type-sp

  • Genomics and phenomics of body mass index reveals a complex disease network - Unknown journal (n.d.) · Unknown authors · PubMed 36581621

    ABSTRACT: Elevated body mass index (BMI) is heritable and associated with many health conditions that impact morbidity and mortality. The study of the genetic association of BMI across a broad range of common disease conditions offers the opportunity to extend current knowledge regarding the breadth and depth of adiposity-related diseases. We identify 906 (364 novel) and 41 (6 novel) genome-wide significant loci for BMI among participants of European (N~1.1 million) and African (N~100,000) ancestry, respectively. Using a BMI genetic risk score including 2446 variants, 316 diagnoses are associated in the Million Veteran Program, with 96.5% showing increased risk. A co-morbidity network analysis reveals seven disease communities containing multiple interconnected diseases associated with BMI


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Diet

  • Emphasize dietary carbohydrate quality Moderate

    Given type 2 diabetes genetic risk from this variant, carbohydrate source and portion control become higher priority for metabolic control

    Prioritize whole grains and legumes; limit refined carbohydrates and added sugars to <25g daily for women, <36g for men

Exercise

  • Regular physical activity for metabolic health Moderate

    Exercise reduces type 2 diabetes and body weight risk; critical intervention given this variant's metabolic associations

    150 minutes/week moderate-intensity aerobic activity or 75 minutes/week vigorous-intensity; add resistance training 2x/week

Lifestyle

  • Body weight and BMI Moderate

    This variant is associated with increased body mass index (GWAS p<1e-8, n>1.1M), indicating metabolic predisposition to weight gain

    Monitor weight monthly; work with healthcare provider on weight management and target BMI <25 kg/m2

Screening

  • Type 2 diabetes screening Moderate

    This variant carries a T allele significantly associated with type 2 diabetes risk (GWAS p<1e-8, n=2.5M)

    Discuss with healthcare provider to establish screening frequency; baseline screening and every 1-2 years thereafter